Cargando…
Biomarkers of Cervical Dysplasia and Carcinoma
Although cervical cytology screening has decreased the incidence of cervical cancer in industrialized countries, HPV-related cervical disease, including premalignant and malignant lesions, continues to represent a major burden on the health care system. Some of the problems include the potential for...
Autores principales: | Hwang, Sonya J., Shroyer, Kenneth R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3205687/ https://www.ncbi.nlm.nih.gov/pubmed/22131995 http://dx.doi.org/10.1155/2012/507286 |
Ejemplares similares
-
Cervical Carcinoma: Oncobiology and Biomarkers
por: Volkova, Larisa V., et al.
Publicado: (2021) -
Cervical Acid Phosphatase: A Biomarker of Cervical Dysplasia and a Potential Surrogate Endpoint for Colposcopy
por: Markovic, Olivera, et al.
Publicado: (2004) -
Molecular Biomarkers of Malignant Transformation in Head and Neck Dysplasia
por: Ranganath, Kushi, et al.
Publicado: (2022) -
The Role of Micronutrients in Human Papillomavirus Infection, Cervical Dysplasia, and Neoplasm
por: Ferrari, Filippo Alberto, et al.
Publicado: (2023) -
Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
por: Rossi, Paolo Giorgi, et al.
Publicado: (2009)